196 related articles for article (PubMed ID: 32634285)
1. CCN1/Cyr61 Is Required in Osteoblasts for Responsiveness to the Anabolic Activity of PTH.
Zhao G; Kim EW; Jiang J; Bhoot C; Charles KR; Baek J; Mohan S; Adams JS; Tetradis S; Lyons KM
J Bone Miner Res; 2020 Nov; 35(11):2289-2300. PubMed ID: 32634285
[TBL] [Abstract][Full Text] [Related]
2. CYR61/CCN1 Regulates Sclerostin Levels and Bone Maintenance.
Zhao G; Huang BL; Rigueur D; Wang W; Bhoot C; Charles KR; Baek J; Mohan S; Jiang J; Lyons KM
J Bone Miner Res; 2018 Jun; 33(6):1076-1089. PubMed ID: 29351359
[TBL] [Abstract][Full Text] [Related]
3. N-cadherin restrains PTH repressive effects on sclerostin/SOST by regulating LRP6-PTH1R interaction.
Yang H; Dong J; Xiong W; Fang Z; Guan H; Li F
Ann N Y Acad Sci; 2016 Dec; 1385(1):41-52. PubMed ID: 27723935
[TBL] [Abstract][Full Text] [Related]
4. Loss of Gsα in the Postnatal Skeleton Leads to Low Bone Mass and a Blunted Response to Anabolic Parathyroid Hormone Therapy.
Sinha P; Aarnisalo P; Chubb R; Poulton IJ; Guo J; Nachtrab G; Kimura T; Swami S; Saeed H; Chen M; Weinstein LS; Schipani E; Sims NA; Kronenberg HM; Wu JY
J Biol Chem; 2016 Jan; 291(4):1631-1642. PubMed ID: 26598522
[TBL] [Abstract][Full Text] [Related]
5. gp130 in late osteoblasts and osteocytes is required for PTH-induced osteoblast differentiation.
Standal T; Johnson RW; McGregor NE; Poulton IJ; Ho PW; Martin TJ; Sims NA
J Endocrinol; 2014 Nov; 223(2):181-90. PubMed ID: 25228504
[TBL] [Abstract][Full Text] [Related]
6. Regulation of beta catenin signaling and parathyroid hormone anabolic effects in bone by the matricellular protein periostin.
Bonnet N; Conway SJ; Ferrari SL
Proc Natl Acad Sci U S A; 2012 Sep; 109(37):15048-53. PubMed ID: 22927401
[TBL] [Abstract][Full Text] [Related]
7. Mitogen-activated protein kinase phosphatase 1 regulates bone mass, osteoblast gene expression, and responsiveness to parathyroid hormone.
Mahalingam CD; Datta T; Patil RV; Kreider J; Bonfil RD; Kirkwood KL; Goldstein SA; Abou-Samra AB; Datta NS
J Endocrinol; 2011 Nov; 211(2):145-56. PubMed ID: 21852324
[TBL] [Abstract][Full Text] [Related]
8. Sustained RANKL response to parathyroid hormone in oncostatin M receptor-deficient osteoblasts converts anabolic treatment to a catabolic effect in vivo.
Walker EC; Poulton IJ; McGregor NE; Ho PW; Allan EH; Quach JM; Martin TJ; Sims NA
J Bone Miner Res; 2012 Apr; 27(4):902-12. PubMed ID: 22190112
[TBL] [Abstract][Full Text] [Related]
9. Retromer in Osteoblasts Interacts With Protein Phosphatase 1 Regulator Subunit 14C, Terminates Parathyroid Hormone's Signaling, and Promotes Its Catabolic Response.
Xiong L; Xia WF; Tang FL; Pan JX; Mei L; Xiong WC
EBioMedicine; 2016 Jul; 9():45-60. PubMed ID: 27333042
[TBL] [Abstract][Full Text] [Related]
10. Low-dose PTH increases osteoblast activity via decreased Mef2c/Sost in senescent osteopenic mice.
Saidak Z; Le Henaff C; Azzi S; Marty C; Marie PJ
J Endocrinol; 2014 Oct; 223(1):25-33. PubMed ID: 25056116
[TBL] [Abstract][Full Text] [Related]
11. Parathyroid hormone (PTH)/PTH-related peptide type 1 receptor (PPR) signaling in osteocytes regulates anabolic and catabolic skeletal responses to PTH.
Saini V; Marengi DA; Barry KJ; Fulzele KS; Heiden E; Liu X; Dedic C; Maeda A; Lotinun S; Baron R; Pajevic PD
J Biol Chem; 2013 Jul; 288(28):20122-34. PubMed ID: 23729679
[TBL] [Abstract][Full Text] [Related]
12. CYR61/CCN1 stimulates proliferation and differentiation of osteoblasts in vitro and contributes to bone remodeling in vivo in myeloma bone disease.
Liu H; Peng F; Liu Z; Jiang F; Li L; Gao S; Wang G; Song J; Ruan E; Shao Z; Fu R
Int J Oncol; 2017 Feb; 50(2):631-639. PubMed ID: 28035364
[TBL] [Abstract][Full Text] [Related]
13. The IRE1α-XBP1 pathway positively regulates parathyroid hormone (PTH)/PTH-related peptide receptor expression and is involved in pth-induced osteoclastogenesis.
Tohmonda T; Yoda M; Mizuochi H; Morioka H; Matsumoto M; Urano F; Toyama Y; Horiuchi K
J Biol Chem; 2013 Jan; 288(3):1691-5. PubMed ID: 23235147
[TBL] [Abstract][Full Text] [Related]
14. Amphiregulin-EGFR signaling mediates the migration of bone marrow mesenchymal progenitors toward PTH-stimulated osteoblasts and osteocytes.
Zhu J; Siclari VA; Liu F; Spatz JM; Chandra A; Divieti Pajevic P; Qin L
PLoS One; 2012; 7(12):e50099. PubMed ID: 23300521
[TBL] [Abstract][Full Text] [Related]
15. The Deletion of Hdac4 in Mouse Osteoblasts Influences Both Catabolic and Anabolic Effects in Bone.
Nakatani T; Chen T; Johnson J; Westendorf JJ; Partridge NC
J Bone Miner Res; 2018 Jul; 33(7):1362-1375. PubMed ID: 29544022
[TBL] [Abstract][Full Text] [Related]
16. Distinct roles for mitogen-activated protein kinase phosphatase-1 (MKP-1) and ERK-MAPK in PTH1R signaling during osteoblast proliferation and differentiation.
Datta NS; Kolailat R; Fite A; Pettway G; Abou-Samra AB
Cell Signal; 2010 Mar; 22(3):457-66. PubMed ID: 19892016
[TBL] [Abstract][Full Text] [Related]
17. Roles of parathyroid hormone (PTH) receptor and reactive oxygen species in hyperlipidemia-induced PTH resistance in preosteoblasts.
Li X; Garcia J; Lu J; Iriana S; Kalajzic I; Rowe D; Demer LL; Tintut Y
J Cell Biochem; 2014 Jan; 115(1):179-88. PubMed ID: 24038594
[TBL] [Abstract][Full Text] [Related]
18. N-cadherin restrains PTH activation of Lrp6/β-catenin signaling and osteoanabolic action.
Revollo L; Kading J; Jeong SY; Li J; Salazar V; Mbalaviele G; Civitelli R
J Bone Miner Res; 2015 Feb; 30(2):274-85. PubMed ID: 25088803
[TBL] [Abstract][Full Text] [Related]
19. EphrinB2/EphB4 inhibition in the osteoblast lineage modifies the anabolic response to parathyroid hormone.
Takyar FM; Tonna S; Ho PW; Crimeen-Irwin B; Baker EK; Martin TJ; Sims NA
J Bone Miner Res; 2013 Apr; 28(4):912-25. PubMed ID: 23165727
[TBL] [Abstract][Full Text] [Related]
20. Kindlin-2 regulates skeletal homeostasis by modulating PTH1R in mice.
Fu X; Zhou B; Yan Q; Tao C; Qin L; Wu X; Lin S; Chen S; Lai Y; Zou X; Shao Z; Wang M; Chen D; Jin W; Song Y; Cao H; Zhang G; Xiao G
Signal Transduct Target Ther; 2020 Dec; 5(1):297. PubMed ID: 33361757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
